Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.

about

Recent advances in ankylosing spondylitis: understanding the disease and management

P2860

Q57821877-50461CE8-F550-4BC7-85E3-93BC9B2DC8B9

P2860

Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.

Item

http://www.wikidata.org/entity/Q36235821

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@ast

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@en

type

Item

label

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@ast

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@en

prefLabel

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@ast

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@en

P1476

Impact of Dose Tapering of Tum ...... ion in Ankylosing Spondylitis.

@en

P2093

Eun Young Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Mi Kwon

http://www.w3.org/2001/XMLSchema#string

Ja-Young Choi

http://www.w3.org/2001/XMLSchema#string

Jin Kyun Park

http://www.w3.org/2001/XMLSchema#string

Jun Won Park

http://www.w3.org/2001/XMLSchema#string

Yeong Wook Song

http://www.w3.org/2001/XMLSchema#string

P2860

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Analyzing longitudinal data with the linear mixed models procedure in SPSS.

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.

Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.

Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order.

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.

Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.

P304

e0168958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0168958

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eun Young Lee

P577

2016-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28033420

http://www.w3.org/2001/XMLSchema#string

P932

5199008

http://www.w3.org/2001/XMLSchema#string

Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.

about

P2860

P2860

Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932